Literature DB >> 1604710

Drugs of abuse: anatomy, pharmacology and function of reward pathways.

G F Koob1.   

Abstract

Drugs of abuse are very powerful reinforcers, and even in conditions of limited access (where the organism is not dependent) these drugs will motivate high rates of operant responding. This presumed hedonic property and the drugs' neuropharmacological specificity provide a means of studying the neuropharmacology and neuroanatomy of brain reward. Three major brain systems appear to be involved in drug reward--dopamine, opioid and GABA. Evidence suggests a midbrain-forebrain-extrapyramidal circuit with its focus in the nucleus accumbens. Data implicating dopamine and opioid systems in indirect sympathomimetic and opiate reward include critical elements in both the nucleus accumbens and ventral tegmental areas. Ethanol reward appears to depend on an interaction with the GABAA receptor complex but may also involve common elements such as dopamine and opioid peptides in this midbrain-forebrain-extrapyramidal circuit. These results suggest that brain reward systems have a multidetermined neuropharmacological basis that may involve some common neuroanatomical elements.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1604710     DOI: 10.1016/0165-6147(92)90060-j

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  392 in total

Review 1.  Neurochemistry and defects of biogenic amine neurotransmitter metabolism.

Authors:  K Hyland
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  Ultrastructural localization of the alpha4-subunit of the neuronal acetylcholine nicotinic receptor in the rat substantia nigra.

Authors:  M M Arroyo-Jim nez; J P Bourgeois; L M Marubio; A M Le Sourd; O P Ottersen; E Rinvik; A Fairén; J P Changeux
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

Review 3.  Regulation of ion channel expression in neural cells by hormones and growth factors.

Authors:  L J Chew; V Gallo
Journal:  Mol Neurobiol       Date:  1998-12       Impact factor: 5.590

4.  Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2.

Authors:  Y Yue; D A Widmer; A K Halladay; D P Cerretti; G C Wagner; J L Dreyer; R Zhou
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

Review 5.  A behavioral/systems approach to the neuroscience of drug addiction.

Authors:  Francis J White
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

6.  Response to novelty as a predictor of cocaine sensitization and conditioning in rats: a correlational analysis.

Authors:  Robert J Carey; Gail DePalma; Ernest Damianopoulos
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

7.  Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders.

Authors:  R A Nolan; R Muir; K Runner; E K Haddad; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2018-12-05       Impact factor: 4.147

8.  The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.

Authors:  Laura Orio; Sunmee Wee; Amy H Newman; Luigi Pulvirenti; George F Koob
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

9.  Enhanced tyrosine hydroxylase phosphorylation in the nucleus accumbens and nucleus tractus solitarius-A2 cell group after morphine-conditioned place preference.

Authors:  A González-Cuello; L Mora; J M Hidalgo; N Meca; C Lasheras; M V Milanés; M L Laorden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-06       Impact factor: 3.000

10.  Topiramate's effects on cocaine-induced subjective mood, craving and preference for money over drug taking.

Authors:  Bankole A Johnson; John D Roache; Nassima Ait-Daoud; Erik W Gunderson; Heather M Haughey; Xin-Qun Wang; Lei Liu
Journal:  Addict Biol       Date:  2012-10-08       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.